Exact Mass: 576.439

Exact Mass Matches: 576.439

Found 300 metabolites which its exact mass value is equals to given mass value 576.439, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

beta-Sitosterol 3-O-beta-D-galactopyranoside

(2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C35H60O6 (576.439)


Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. beta-Sitosterol 3-O-beta-D-galactopyranoside is found in herbs and spices. beta-Sitosterol 3-O-beta-D-galactopyranoside is a constituent of Hibiscus sabdariffa (roselle) leaves. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

Schottenol 3-glucoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


Constituent of citron-melon fruits (Citrullus lanatus variety citroides). Schottenol 3-glucoside is found in watermelon, fruits, and spinach. Schottenol 3-glucoside is found in fruits. Schottenol 3-glucoside is a constituent of citron-melon fruits (Citrullus lanatus var. citroides).

   

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

(2S)-3-(dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

(2S)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Coriandrinol

(2R,3R,4S,5S,6R)-2-{[(1S,2R,10S,11S,15R)-14-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


Coriandrinol belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. Coriandrinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Coriandrinol can be found in coriander, which makes coriandrinol a potential biomarker for the consumption of this food product. Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

Bacosterol-3-O-beta-D-glucopyranoside

Bacosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-Sitosteryl-D-glucoside

beta-Sitosteryl-D-glucoside

C35H60O6 (576.439)


   

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

C35H60O6 (576.439)


   

sitosterol-3beta-glucopyranoside

sitosterol-3beta-glucopyranoside

C35H60O6 (576.439)


   

SCHEMBL11913139

SCHEMBL11913139

C35H60O6 (576.439)


   

beta-sitosterol beta-D-glucopyranoside

beta-sitosterol beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-sitosterol-3-O-beta-D-glucopyranoside

beta-sitosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-sitosterol-3-O-beta-D-glucoside

beta-sitosterol-3-O-beta-D-glucoside

C35H60O6 (576.439)


   

Daucosterol

(2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C35H60O6 (576.439)


Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. A steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

beta-sitosterol-beta-D-glucoside

beta-sitosterol-beta-D-glucoside

C35H60O6 (576.439)


   

beta-Sitosterylglucosid

beta-Sitosterylglucosid

C35H60O6 (576.439)


   

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

C35H60O6 (576.439)


   

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

C35H60O6 (576.439)


   

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-Sitosterol 3-O-beta-D-galactopyranoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

Schottenol glucoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

glucoclionasterol

poriferast-5-en-3beta-yl beta-D-glucopyranoside

C35H60O6 (576.439)


   

ST 29:1;O;Hex

stigmast-5-en-3beta-yl beta-D-galactopyranoside

C35H60O6 (576.439)


   
   

Sitosterol glucoside

3-O-(beta-D-glucopyranosyl)-stigmast-5-en-3beta-ol

C35H60O6 (576.439)


   

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

C35H60O6 (576.439)


   

C35 phosphodolichol

C35 phosphodolichol

C35H61O4P (576.4307)


   

2,3-di(octanoyloxy)propyl (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

2,3-di(octanoyloxy)propyl (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H60O6 (576.439)


   

Sitosteryl glucoside

Sitosteryl glucoside

C35H60O6 (576.439)


   

C35-phosphodolichol

C35-phosphodolichol

C35H61O4P (576.4307)


A dolichyl phosphate in which the dolichyl moiety contains six prenyl units

   

TG(32:3)

TG(16:0_6:0_10:3)

C35H60O6 (576.439)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5r,6r)-4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C35H60O6 (576.439)


   

(2s,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2s,3s,4r,5r,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3s,4r,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

6′-palmitoxyl-β-daucosterin

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN012746","Ingredient_name": "6\u2032-palmitoxyl-\u03b2-daucosterin","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33331","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

aucosterol

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN017340","Ingredient_name": "aucosterol","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33332","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

bacosterol-3-o-β-d-glucopyranoside

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN017504","Ingredient_name": "bacosterol-3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CC=CC2CCC3CC(CCC3(C2=CCC1C)C)OC4C(C(C(C(O4)CO)O)O)O)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2095","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-daucosterin

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018050","Ingredient_name": "\u03b2-daucosterin","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35374","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-daucostero

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018051","Ingredient_name": "\u03b2-daucostero","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39817","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-dauosterol

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018054","Ingredient_name": "\u03b2-dauosterol","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36019","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-sitosterol-3-o-β-d-glucoside

β-sitosterol-3-o-β-d-gluco-side; beta-sitosterol-3-o-beta-d-gluco-side; beta-sitosterol-3-o-beta-d-glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018290","Ingredient_name": "\u03b2-sitosterol-3-o-\u03b2-d-glucoside","Alias": "\u03b2-sitosterol-3-o-\u03b2-d-gluco-side; beta-sitosterol-3-o-beta-d-gluco-side; beta-sitosterol-3-o-beta-d-glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT01935","TCMID_id": "19969;23905;25113","TCMSP_id": "NA","TCM_ID_id": "10347;10348;6243","PubChem_id": "12309073","DrugBank_id": "NA"}

   

β-sitosterol-α-d-glucoside

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018296","Ingredient_name": "\u03b2-sitosterol-\u03b1-d-glucoside","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19970","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

beta-Sitosterol-alpha-glucoside

beta-sitosterol-alpha-glucoside; β-sitosterol-α- glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018297","Ingredient_name": "beta-Sitosterol-alpha-glucoside","Alias": "beta-sitosterol-alpha-glucoside; \u03b2-sitosterol-\u03b1- glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.95","OB_score": "20.63193686","CAS_id": "NA","SymMap_id": "SMIT01014","TCMID_id": "25282;34477","TCMSP_id": "MOL001770","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

beta-sitosterol-beta-d-glucoside

β- sitosterol-β-D- glucoside; β-sitosterol-β-D-glucoside; β-sitosterol-β-d-glucoside; β-sitosterol- β- D- glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018301","Ingredient_name": "beta-sitosterol-beta-d-glucoside","Alias": "\u03b2- sitosterol-\u03b2-D- glucoside; \u03b2-sitosterol-\u03b2-D-glucoside; \u03b2-sitosterol-\u03b2-d-glucoside; \u03b2-sitosterol- \u03b2- D- glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "19.57852635","CAS_id": "NA","SymMap_id": "SMIT08823;SMIT17727","TCMID_id": "25281;41224;35764;19971;38323","TCMSP_id": "MOL007375","TCM_ID_id": "17880","PubChem_id": "91884650","DrugBank_id": "NA"}

   

β-sitosterol- D- glucoside

beta-sitosterol-d-glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018304","Ingredient_name": "\u03b2-sitosterol- D- glucoside","Alias": "beta-sitosterol-d-glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35368","TCMSP_id": "NA","TCM_ID_id": "19707;21899","PubChem_id": "12309060","DrugBank_id": "NA"}

   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7r,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7r,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[10-(5-ethyl-6-methylheptan-2-yl)-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[10-(5-ethyl-6-methylheptan-2-yl)-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2s,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4r,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(3as,3bs,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3as,3bs,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3s,4s,5s,6s)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[(1r,7s,9ar,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[(1r,7s,9ar,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

4-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

4-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C35H60O6 (576.439)


   

(2s,3s,4r,5r,6s)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)